Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 – Support for clinical studies on advanced cancer treatment-Reference-Cited by-同舟云学术

Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 – Support for clinical studies on advanced cancer treatment

Published:2017-08-10 Issue:8 Volume:12 Page:e0182715
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kuryk Lukasz^ORCID,Vassilev Lotta,Ranki Tuuli,Hemminki Akseli,Karioja-Kallio Aila,Levälampi Onerva,Vuolanto Antti,Cerullo Vincenzo,Pesonen Sari

Funder

Marie Curie Innovative Training Network (ITN), ADVance

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus;I Diaconu;Cancer research,2012

2. How tumors escape immune destruction and what we can do about it;E Gilboa;Cancer Immunology, Immunotherapy,1999

3. Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF;A Koski;Molecular therapy: the journal of the American Society of Gene Therapy,2010

4. Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data;S Pesonen;Molecular pharmaceutics,2011

5. Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors;S Pesonen;Gene therapy,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy;Journal of Translational Medicine;2024-03-07

2. Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model;Frontiers in Oncology;2023-11-20

3. Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models;Molecular Therapy - Oncolytics;2023-03

4. A Meta-analysis on the Effectiveness of Extracellular Vesicles as Nanosystems for Targeted Delivery of Anticancer Drugs;Molecular Pharmaceutics;2023-01-03

5. DNA Origami Disguises Herpes Simplex Virus 1 Particles and Controls Their Virulence;Molecules;2022-10-23